Geode Capital Management, LLC Lyell Immunopharma, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,019,961 shares of LYEL stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,019,961

Previous 4,012,053 0.2%

Holding current value

$2.45 Million

Previous $5.82 Million 4.64%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.13 - $1.88 $8,936 - $14,867	7,908 Added 0.2%	4,019,961 $5.55 Million
Q2 2024 Aug 09, 2024	SELL	$1.3 - $3.01 $6,458 - $14,953	-4,968 Reduced 0.12%	4,012,053 $5.82 Million
Q1 2024 May 13, 2024	BUY	$1.71 - $3.07 $136,237 - $244,589	79,671 Added 2.02%	4,017,021 $8.96 Million
Q4 2023 Feb 13, 2024	BUY	$1.39 - $2.35 $390,405 - $660,037	280,867 Added 7.68%	3,937,350 $7.64 Million
Q3 2023 Nov 13, 2023	BUY	$1.45 - $3.35 $406,949 - $940,194	280,655 Added 8.31%	3,656,483 $5.38 Million
Q2 2023 Aug 11, 2023	BUY	$1.89 - $3.86 $354,172 - $723,336	187,393 Added 5.88%	3,375,828 $10.7 Million
Q1 2023 May 15, 2023	BUY	$1.97 - $3.58 $268,767 - $488,419	136,430 Added 4.47%	3,188,435 $7.52 Million
Q4 2022 Feb 13, 2023	BUY	$2.78 - $8.09 $281,766 - $819,961	101,355 Added 3.44%	3,052,005 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$5.54 - $8.27 $5.95 Million - $8.89 Million	1,074,563 Added 57.28%	2,950,650 $21.6 Million
Q2 2022 Aug 12, 2022	BUY	$3.68 - $6.8 $1.55 Million - $2.87 Million	421,854 Added 29.01%	1,876,087 $12.2 Million
Q1 2022 May 13, 2022	BUY	$5.05 - $7.7 $4.52 Million - $6.9 Million	895,507 Added 160.28%	1,454,233 $7.34 Million
Q4 2021 Feb 11, 2022	BUY	$7.13 - $15.19 $191,376 - $407,714	26,841 Added 5.05%	558,726 $4.32 Million
Q3 2021 Nov 12, 2021	BUY	$11.0 - $17.95 $3.93 Million - $6.42 Million	357,465 Added 204.94%	531,885 $7.87 Million
Q2 2021 Aug 13, 2021	BUY	$15.99 - $16.89 $2.79 Million - $2.95 Million	174,420 New	174,420 $2.83 Million

Others Institutions Holding LYEL

# of Institutions

121

Shares Held

142M

Call Options Held

18.1K

Put Options Held

200

View Full List

About Lyell Immunopharma, Inc.

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $151M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

More about LYEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Lyell Immunopharma, Inc. Transaction History